Your browser doesn't support javascript.
loading
Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
Elliott, Jessie A; Klevebro, Fredrik; Mantziari, Styliani; Markar, Sheraz R; Goense, Lucas; Johar, Asif; Lagergren, Pernilla; Zaninotto, Giovanni; van Hillegersberg, Richard; van Berge Henegouwen, Mark I; Schäfer, Markus; Nilsson, Magnus; Hanna, George B; Reynolds, John V.
Afiliación
  • Elliott JA; Trinity St. James's Cancer Institute, Trinity College Dublin, and St. James's Hospital, Dublin, Ireland.
  • Klevebro F; CLINTEC, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Mantziari S; Lausanne University Hospital CHUV and University of Lausanne UNIL, Lausanne, Switzerland.
  • Markar SR; Surgical Interventional Trials Unit, Nuffield Department of Surgery, University of Oxford, Oxford, UK.
  • Goense L; Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Johar A; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Lagergren P; Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Zaninotto G; Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • van Hillegersberg R; Department of Surgery and Cancer, Imperial College London, St. Mary's Hospital, London, UK.
  • van Berge Henegouwen MI; Department of Surgery and Cancer, Imperial College London, St. Mary's Hospital, London, UK.
  • Schäfer M; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Nilsson M; Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.
  • Hanna GB; Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Reynolds JV; Lausanne University Hospital CHUV and University of Lausanne UNIL, Lausanne, Switzerland.
Ann Surg ; 278(5): 692-700, 2023 11 01.
Article en En | MEDLINE | ID: mdl-37470379
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Ann Surg Año: 2023 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Ann Surg Año: 2023 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Estados Unidos